BioDelivery Sciences International is a biotechnology company that specializes in pain management and addiction medicine. The company’s products and candidates are based on BioErodible MucoAdhesive, a proprietary B drug delivery technology. BEMA is a small, erodible polymer film for application to the buccal mucosa, which is used in approved products and candidates such as ONSOLIS (fentanyl buccal soluble film) for treating cancer pain; BUNAVAIL (buprenorphine and naloxone buccal film) to treat opioid dependence; and product candidate BELBUCA (formerly referred to as BEMA Buprenorphine), which aims to treat chronic pain.